Search

Your search keyword '"Etra A"' showing total 565 results

Search Constraints

Start Over You searched for: Author "Etra A" Remove constraint Author: "Etra A"
565 results on '"Etra A"'

Search Results

1. The Influence of Social Assistance and Demographic Factors on Income and Consumption of Poor Households during the Covid-19 Pandemic in the Coastal Area of South Sulawesi

2. The Occhialini-Dilworth Archives

4. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

5. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

6. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

7. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

8. A Day 14 Endpoint for Acute GVHD Clinical Trials

9. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

10. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

11. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

12. Effective treatment of low-risk acute GVHD with itacitinib monotherapy

13. Peran Mahkamah Konstitusi dalam Perlindungan Hak Pilih dalam Negara Hukum Demokratis

14. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

15. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

17. Latissimus Dorsi Myocutaneous Flap Procedure in a Swine Model

18. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

19. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis

20. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis

21. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)

22. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd

24. A Creative “Nanotown”

26. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

27. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

29. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

31. The utility of biomarkers in acute GVHD prognostication

32. Opioid-Prescribing Guidelines for Common Surgical Procedures: An Expert Panel Consensus

33. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

34. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease

39. Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

40. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

44. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd

46. REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE

47. Application of the concept of justice as fairness in limiting the voting rights of former convicts to run for elected public officials

48. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

Catalog

Books, media, physical & digital resources